Drugs Made In America Acquisition (DMAA) Long-Term Debt Repayments (2025)
Drugs Made In America Acquisition (DMAA) posted Long-Term Debt Repayments of $900,000 for FY2025, down 30.8% from $1.3 million in FY2024.
Powered by 
Analysis
Drugs Made In America Acquisition (DMAA) Long-Term Debt Repayments (2025) Analysis & Trends
- Business Quant data shows DMAA's Long-Term Debt Repayments at $1.3 million in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | BlackRock | 165.40 Bn | 111.76 Bn | - | - |
| 2 | Spdr Gold Trust | 133.61 Bn | -424.39 Bn | - | - |
| 3 | Blackstone | 84.03 Bn | 78.95 Bn | - | 803.63 Mn |
| 4 | Brookfield | 82.79 Bn | -82.59 Bn | 4.47 Bn | - |
| 5 | Kkr | 80.75 Bn | 47.23 Bn | - | 5.24 Bn |
| 6 | Brookfield Asset Management | 71.44 Bn | 67.69 Bn | - | - |
| 7 | Apollo Global Management | 66.43 Bn | 4.11 Bn | 10.56 Bn | 3.39 Bn |
| 8 | Wheaton Precious Metals | 61.87 Bn | 57.29 Bn | 687.86 Mn | -728.00 Mn |
| 9 | Franco Nevada | 46.42 Bn | 43.78 Bn | 451.00 Mn | - |
| 10 | Drugs Made In America Acquisition | 335.55 Mn | 335.55 Mn | - | - |
API Access
Drugs Made In America Acquisition Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=DMAA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "DMAA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=DMAA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();